期刊文献+

nm23、Ⅳ型胶原、PCNA在非小细胞肺癌中表达的临床意义 被引量:4

Clinic significance of nm23, collage Ⅳ and PCNA expression in non-small cell lung cancer
下载PDF
导出
摘要 目的 探讨nm2 3、Ⅳ型胶原、增殖核抗原 (PCNA)在非小细胞肺癌 (NSCLC)中表达的意义。方法 采用SP免疫组化法检测 84例NSCLC组织中nm2 3、Ⅳ型胶原、PCNA的表达。其中鳞癌 42例 ,腺癌 42例 ;按TNM分期Ⅰ期 2 7例 ,Ⅱ期 2 4例 ,Ⅲ期 2 4例 ,Ⅳ期 9例。资料分析采用 χ2 检验。结果 nm2 3、Ⅳ型胶原、PCNA在NSCLC中表达的阳性率分别为 6 0 .7% (5 1 /84)、75 .0 % (6 3 /84)和 5 3 .6 % (45 /84)。nm2 3、Ⅳ型胶原表达与肺鳞癌淋巴结转移呈负相关 ,Ⅳ型胶原、PCNA与NSCLC分化程度相关 ,nm2 3、Ⅳ型胶原、PCNA表达与TNM分期无关。结论 nm2 3、Ⅳ型胶原、PCNA参与NSCLC转移过程的调节 ,可以作为评价NSCLC转移能力的指标。 Objective To study the significance of nm23, collagen Ⅳ and PCNA expressions in non-small cell lung cancer. Methods Expressions of the nm23, collagen Ⅳ and PCNA in 84 cases of non small cell lung cancer were examined with SP immunohistochemical technique. Of the 84 cases, there were squamous cell carcinoma 42, adenocarcinoma 42, stage Ⅰ 27, stage Ⅱ 24, stage Ⅲ 24, and stage Ⅳ 9. Statistical analysis was performed with χ 2 test. Results Expressions of the nm23, collagen Ⅳ and PCNA in 84 cases of non small cell lung cancer were 60.7% (51/84),75.0% (63/84) and 53.6% (45/84) respectively. There was negative correlation between the lymph node metastasis and the expressions of nm23 and collagen Ⅳ in squamous cell carcinoma, and the expressions of collagen Ⅳ and PCNA were associated with tumor differentiation. No correlation was found between TNM stage and expressions of nm23, collagen Ⅳ and PCNA . Conclusion The results indicate that nm23, collagen Ⅳ and PCNA participate the modulation of metastasis of non small cell lung cancer and that they may be used to evaluate the potential of metastasis.
出处 《中国肺癌杂志》 CAS 2001年第6期469-470,共2页 Chinese Journal of Lung Cancer
关键词 肺肿瘤 NM23 Ⅳ型胶原 增殖核抗原 NSCLC 肿瘤转移 Lung neoplasms nm23 Collagen Ⅳ PCNA
  • 相关文献

参考文献4

二级参考文献1

共引文献75

同被引文献27

  • 1雷文东,张汝刚,闫水忠,王秀琴,牟巨伟,张大为,吴旻.nm23基因在人肺癌中的表达及其与肺癌淋巴结转移的关系[J].中华肿瘤杂志,1994,16(4):277-279. 被引量:58
  • 2徐震逸,邵杰,张月桂,孙凤林,郑大勇,李永庆,李永堂,李殿俊,巴德年.人肺癌浸润性淋巴细胞的功能及在免疫过继疗法中的应用[J].肿瘤,1989,9(5):193-195. 被引量:6
  • 3陈晓峰 周清华 等.nm23基因产物在人非小细胞肺癌中的表达及其预后关系研究[J].肺癌,1997,1(2):36-36.
  • 4Travis WD, Colby TV, Corrin B,et al. Histological typing of lung and pleural tumors. WHO Intemation Histological Classification of Tum-ors[J]. 3rd ed. Berlin:Springer, 1999,143(19):984~990
  • 5Abe S.Molecular biological prognostic markers in lung cancer[J].Nippon Geka Gakkai Zasshi, 1997, 98(1):2~7
  • 6GarciaR,JoveR.Activation of STAT transcription factor sinoncogenictyrosinekinasesignaling[J].JBomedSci,1998,5(2):79-85.
  • 7FromowitZ FB,ViolaMV,Chao S,et al.rasp l expresSion in the progresSionofbreastcancer[J].HumPatho,1987.18(12):1 268-1 275.
  • 8ZhongZ,WenZ,Darnell JEJr.Stat3 and Stat4:member sof the family of Signal transducer sandac tivator sof transcription[J].ProcNatlAcadSci USA,1994,91 (11):4806-4810
  • 9Alas S,Bonavida B.Rituximab Inactivates signaltransducer and activation of transcrption3(Stat3) activity in B -non-Hodgkin's lymphoma through inhibition of the Interleukin 10 autocrine/paracrine loop and results in down regulation of Bcl-2 and sensitization to cytotoxic drugs[J].cancerRes,2001,61(13):5137-5144.
  • 10Puthier D,Thabard W,Rapp M,etal.Interferonal alpha extends the survival of human myeloma cells through an upregulation of theMcl-lantiapoptoticmolecule[J].BrJ Haematol,2001,112 (3):358-363.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部